4
Changes in Ownership
Tempest Therapeutics, Inc. Filed Acc 0001140361-21-022783
Options or other derivatives
- Chief Executive Officer acquired 2,170,988 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Brady Stephen R Chief Executive Officer | 2021-06-25 | Grant or award · Stock Option (Right to Buy) | +110,432 | 110,432 | D | ||
| Brady Stephen R Chief Executive Officer | 2021-06-25 | Grant or award · Stock Option (Right to Buy) | +70,256 | 70,256 | D | ||
| Brady Stephen R Chief Executive Officer | 2021-06-25 | Grant or award · Stock Option (Right to Buy) | +8,050 | 8,050 | D | ||
| Brady Stephen R Chief Executive Officer | 2021-06-25 | Grant or award · Stock Option (Right to Buy) | +1,982,250 | 1,982,250 | D | ||
Loading xslF345X03/form4.xml…